Literature DB >> 18018484

Animal models of Parkinson's disease: similarities and differences between the disease and models.

Nobutaka Hattori1, Shigeto Sato.   

Abstract

Parkinson's disease (PD) is a progressive movement disorder characterized by resting tremor, rigidity, akinesia, and postural instability. In addition, PD is characterized by the appearance of Lewy bodies in the remaining neurons. The exact etiology for this disease is still unknown. However, genetic-environmental interaction could contribute to the pathomechanisms of PD. Indeed, seven causative genes responsible for familial PD have been identified. Since discovery of familial PD (FPD), genetic PD models have been developed. Moreover, new PD models using neurotoxins have been reported. In this review, the similarities between human PD and PD models such as genetic mice and Drosophila models are reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18018484     DOI: 10.1111/j.1440-1789.2007.00842.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  8 in total

1.  Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.

Authors:  Wei Zhang; Kester Phillips; Albert R Wielgus; Jie Liu; Alberto Albertini; Fabio A Zucca; Rudolph Faust; Steven Y Qian; David S Miller; Colin F Chignell; Belinda Wilson; Vernice Jackson-Lewis; Serge Przedborski; Danielle Joset; John Loike; Jau-Shyong Hong; David Sulzer; Luigi Zecca
Journal:  Neurotox Res       Date:  2009-12-03       Impact factor: 3.911

2.  Protein aggregation containing β-amyloid, α-synuclein and hyperphosphorylated τ in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure.

Authors:  Rodrigo S Chaves; Thaiany Q Melo; Stephanie A Martins; Merari F R Ferrari
Journal:  BMC Neurosci       Date:  2010-11-10       Impact factor: 3.288

3.  Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis.

Authors:  Emanuele Ferrari; Mireille Engelen; Enrico Monzani; Michela Sturini; Stefania Girotto; Luigi Bubacco; Luigi Zecca; Luigi Casella
Journal:  J Biol Inorg Chem       Date:  2012-10-31       Impact factor: 3.358

Review 4.  Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.

Authors:  Fabio A Zucca; Juan Segura-Aguilar; Emanuele Ferrari; Patricia Muñoz; Irmgard Paris; David Sulzer; Tadeusz Sarna; Luigi Casella; Luigi Zecca
Journal:  Prog Neurobiol       Date:  2015-10-09       Impact factor: 11.685

5.  Thiazolidinediones and Parkinson Disease: A Cohort Study.

Authors:  John G Connolly; Katsiaryna Bykov; Joshua J Gagne
Journal:  Am J Epidemiol       Date:  2015-10-22       Impact factor: 4.897

6.  PET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133).

Authors:  James S Toomey; Shilpa Bhatia; La'Wanda T Moon; Elysse A Orchard; Kerrie H Tainter; Stephen J Lokitz; Tracee Terry; J Michael Mathis; Andrew D Penman
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

7.  Tremorgenesis: a new conceptual scheme using reciprocally innervated circuit of neurons.

Authors:  Mario Manto
Journal:  J Transl Med       Date:  2008-11-26       Impact factor: 5.531

8.  8-OH-DPAT (5-HT1A agonist) Attenuates 6-Hydroxy- dopamine-induced catalepsy and Modulates Inflammatory Cytokines in Rats.

Authors:  Hamdolah Sharifi; Alireza Mohajjel Nayebi; Safar Farajnia
Journal:  Iran J Basic Med Sci       Date:  2013-12       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.